94 related articles for article (PubMed ID: 21575915)
1. Linking interferon regulatory factors to the pathogenesis of human lupus.
Patel DR
Transl Res; 2011 Jun; 157(6):323-5. PubMed ID: 21575915
[No Abstract] [Full Text] [Related]
2. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
3. A compass that points to lupus: genetic studies on type I interferon pathway.
Kyogoku C; Tsuchiya N
Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
[TBL] [Abstract][Full Text] [Related]
4. The genetics and biology of Irf5-mediated signaling in lupus.
Kozyrev SV; Alarcon-Riquelme ME
Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.
Santana-de Anda K; Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
Autoimmun Rev; 2011 Dec; 11(2):98-103. PubMed ID: 21872684
[TBL] [Abstract][Full Text] [Related]
6. Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha.
Lichtman EI; Helfgott SM; Kriegel MA
Clin Immunol; 2012 Jun; 143(3):210-21. PubMed ID: 22525889
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factors: critical mediators of human lupus.
Jensen MA; Niewold TB
Transl Res; 2015 Feb; 165(2):283-95. PubMed ID: 25445206
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha: a new target for therapy in systemic lupus erythematosus?
Crow MK
Arthritis Rheum; 2003 Sep; 48(9):2396-401. PubMed ID: 13130457
[No Abstract] [Full Text] [Related]
9. Genetic association of interferon-alpha subtypes 1, 2 and 5 in systemic lupus erythematosus.
Hirankarn N; Tangwattanachuleeporn M; Wongpiyabovorn J; Wongchinsri J; Avihingsanon Y
Tissue Antigens; 2008 Dec; 72(6):588-92. PubMed ID: 19000144
[TBL] [Abstract][Full Text] [Related]
10. Lack of interaction between systemic lupus erythematosus-associated polymorphisms in TYK2 and IRF5.
Suarez-Gestal M; Calaza M; Gonzalez A
J Rheumatol; 2010 Mar; 37(3):676-7; author reply 678. PubMed ID: 20197570
[No Abstract] [Full Text] [Related]
11. Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese.
Siu HO; Yang W; Lau CS; Chan TM; Wong RW; Wong WH; Lau YL; Alarcon-Riquelme ME
J Rheumatol; 2008 Feb; 35(2):360-2. PubMed ID: 18260169
[No Abstract] [Full Text] [Related]
12. The genetic contribution to systemic lupus erythematosus.
Criswell LA
Bull NYU Hosp Jt Dis; 2008; 66(3):176-83. PubMed ID: 18937628
[TBL] [Abstract][Full Text] [Related]
13. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
[TBL] [Abstract][Full Text] [Related]
14. An update on pathogenesis of systemic lupus erythematosus.
Ahmadpoor P; Dalili N; Rostami M
Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha as a primary pathogenic factor in human lupus.
Niewold TB
J Interferon Cytokine Res; 2011 Dec; 31(12):887-92. PubMed ID: 21923413
[TBL] [Abstract][Full Text] [Related]
16. New evidence for the role of interferon regulatory factor 5 in the development of systemic lupus erythematosus: comment on the article by Tada et al.
Pan HF; Leng RX; Ye DQ
Arthritis Rheum; 2011 Aug; 63(8):2543. PubMed ID: 21437872
[No Abstract] [Full Text] [Related]
17. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes.
Li J; Liu Y; Xie C; Zhu J; Kreska D; Morel L; Mohan C
Arthritis Rheum; 2005 Oct; 52(10):3063-72. PubMed ID: 16200585
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus: all roads lead to type I interferons.
Pascual V; Farkas L; Banchereau J
Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
